Women's feedback on a chemopreventive trial for cervical dysplasia☆☆☆
Abstract
This study identifies the risks, benefits, and social influences affecting the decision to participate in a chemoprevention trial for cervical dysplasia. Women from three clinical sites in southeastern Michigan were invited to participate in a semi-structured interview. In previous studies, minority women have significant barriers to participation in clinical trials. However, in this study, women (63% black, 26% white, and 9% other ethnicity), were interested in participating and reported only moderate barriers. These barriers could easily be addressed with resources available to investigators. Copyright 2003, Elsevier Science (USA). All rights reserved.
No full text is available. To read the body of this article, please view the PDF online.
☆ Supported in part by the National Cancer Institute grants CA68291 and CA80846.
☆☆ Address reprint requests to Mack T. Ruffin IV, MD, MPH, Department of Family Medicine, University of Michigan, 1018 Fuller Street, Ann Arbor, MI 48109-0708.
PII: S0897-1897(02)10901-3
doi:10.1053/apnr.2003.016022
© 2003 Published by Elsevier Inc.
